Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


22.07.2024

1 Aliment Pharmacol Ther
3 Am J Gastroenterol
3 Clin Gastroenterol Hepatol
1 Dig Dis
1 Dig Dis Sci
3 Dis Colon Rectum
1 Eur J Gastroenterol Hepatol
2 Gastroenterology
1 Gut
1 Hum Pathol
6 Inflamm Bowel Dis
2 J Crohns Colitis
2 Lancet Gastroenterol Hepatol
2 N Engl J Med
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. BOGATIC D, Bryant RV
    Letter: Microbial manipulation for primary sclerosing cholangitis-associated inflammatory bowel disease-hope on the horizon.
    Aliment Pharmacol Ther. 2024 Jul 16. doi: 10.1111/apt.18098.
    PubMed        


    Am J Gastroenterol

  2. PINNUCK B, Lynch KD
    Mortality in Acute Severe Ulcerative Colitis - Still an Alarming and Real Complication in the Era of Advanced Therapies.
    Am J Gastroenterol. 2024 Jul 16. doi: 10.14309/ajg.0000000000002917.
    PubMed        

  3. CALAFAT M, Suria C, Mesonero F, de Francisco R, et al
    HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study of the ENEIDA registry.
    Am J Gastroenterol. 2024 Jul 15. doi: 10.14309/ajg.0000000000002965.
    PubMed         Abstract available

  4. SHAH RS, Hu JH, Bachour S, Joseph A, et al
    Histologic Activity from Neoterminal Ileal Biopsies in Patients with Crohn's Disease in Endoscopic Remission is Associated with Postoperative Recurrence.
    Am J Gastroenterol. 2024 Jul 15. doi: 10.14309/ajg.0000000000002963.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  5. MA C, Solitano V, Danese S, Jairath V, et al
    THE FUTURE OF CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE.
    Clin Gastroenterol Hepatol. 2024 Jul 16:S1542-3565(24)00635.
    PubMed         Abstract available

  6. CHAVANNES M, Dolinger MT, Cohen-Mekelburg S, Abraham B, et al
    AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary.
    Clin Gastroenterol Hepatol. 2024 Jul 10:S1542-3565(24)00454.
    PubMed         Abstract available

  7. LOPES EW, Turpin W, Croitoru K, Colombel JF, et al
    Prediction and Prevention of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2024 Jul 10:S1542-3565(24)00597.
    PubMed        


    Dig Dis

  8. SOKIC-MILUTINOVIC A, Milosavljevic T
    Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy.
    Dig Dis. 2024;42:325-335.
    PubMed         Abstract available


    Dig Dis Sci

  9. MU J, Maeda K, Ohashi A, Urano T, et al
    Monoclonal Antibodies Against Mature Interleukin-18 Ameliorate Colitis and Repair Goblet Cell Function.
    Dig Dis Sci. 2024;69:2573-2585.
    PubMed         Abstract available


    Dis Colon Rectum

  10. CASAS MA, Murdoch Duncan NS, Valinoti AC, Bun ME, et al
    Kono-S Anastomosis Technique for Recurrent Crohn's Disease.
    Dis Colon Rectum. 2024 Jul 17. doi: 10.1097/DCR.0000000000003436.
    PubMed        

  11. PEROTTI S, Mineccia M, Massucco P, Gonella F, et al
    Laparoscopic Proctectomy, Ileoanal Pouch Creation and Transanal Transection With Single Stapled Anastomosis for Ulcerative Colitis.
    Dis Colon Rectum. 2024 Jul 17. doi: 10.1097/DCR.0000000000003431.
    PubMed        

  12. BULDUKOGLU OC
    Factors Affecting Surgical Outcomes in Patients With IBD.
    Dis Colon Rectum. 2024;67:e1509.
    PubMed        


    Eur J Gastroenterol Hepatol

  13. KAMEL AY, Johnson ZD, Hernandez I, Nguyen C, et al
    Micronutrient deficiencies in inflammatory bowel disease: an incidence analysis.
    Eur J Gastroenterol Hepatol. 2024 Jul 16. doi: 10.1097/MEG.0000000000002821.
    PubMed         Abstract available


    Gastroenterology

  14. MULANAX C, Velayos FS
    Shot heard around the world? Subcutaneous Infliximab (CT-P13) as Maintenance Therapy for Inflammatory Bowel Disease.
    Gastroenterology. 2024 Jul 11:S0016-5085(24)05207.
    PubMed        

  15. RUDBAEK JJ, Borbye-Lorenzen N, Poulsen GJ, Koziol A, et al
    Inflammatory markers at birth and risk of early onset inflammatory bowel disease.
    Gastroenterology. 2024 Jul 13:S0016-5085(24)05210.
    PubMed        


    Gut

  16. HOV JR
    Sclerosing cholangitis and inflammatory bowel disease: a paradoxical relationship?
    Gut. 2024 Jul 17:gutjnl-2024-332835. doi: 10.1136/gutjnl-2024-332835.
    PubMed        


    Hum Pathol

  17. JU JY, Escobar DJ, Xue Y, Booth AL, et al
    Small Bowel Pyloric Metaplasia is Associated with Lower Rates of Earlier Recurrence of Crohn's Disease after Resection.
    Hum Pathol. 2024 Jul 17:105629. doi: 10.1016/j.humpath.2024.105629.
    PubMed         Abstract available


    Inflamm Bowel Dis

  18. PETROV JC, Desai AA, Kochhar GS, Crosby SK, et al
    Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study.
    Inflamm Bowel Dis. 2024 Jul 12:izae147. doi: 10.1093.
    PubMed         Abstract available

  19. DAHIYA DS, Jena A, Bapaye J, Mohan BP, et al
    Endoscopic Balloon Dilatation of Ileal Pouch-Anal Anastomosis Strictures in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2024 Jul 16:izae128. doi: 10.1093.
    PubMed         Abstract available

  20. COELHO T, Cheng G, Lewis S, Ashton JJ, et al
    Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Jul 16:izae126. doi: 10.1093.
    PubMed         Abstract available

  21. REGUEIRO M, Siegmund B, Horst S, Moslin R, et al
    Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis.
    Inflamm Bowel Dis. 2024 Jul 17:izae136. doi: 10.1093.
    PubMed         Abstract available

  22. YZET C, Meudjo E, Brazier F, Hautefeuille V, et al
    Intestinal Ultrasound, Fecal Calprotectin, and Their Combination to Predict Endoscopic Mucosal Healing in Ulcerative Colitis: A Real-Life Cross-Sectional Study.
    Inflamm Bowel Dis. 2024 Jul 18:izae145. doi: 10.1093.
    PubMed         Abstract available

  23. KUENZIG ME, Walters TD, Mack DR, Griffiths AM, et al
    High Healthcare Costs in Childhood Inflammatory Bowel Disease: Development of a Prediction Model Using Linked Clinical and Health Administrative Data.
    Inflamm Bowel Dis. 2024 Jul 19:izae148. doi: 10.1093.
    PubMed         Abstract available


    J Crohns Colitis

  24. MA C, Feagan BG, Wang Z, Zou G, et al
    Re-evaluating Methods for Assessing Differences in Response in Ileal vs. Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY Trial.
    J Crohns Colitis. 2024 Jul 20:jjae113. doi: 10.1093.
    PubMed         Abstract available

  25. INCIURAITE R, Ramonaite R, Kupcinskas J, Dalgediene I, et al
    The microRNA expression in crypt-top and crypt-bottom colonic epithelial cell populations demonstrates cell-type specificity and correlates with endoscopic activity in ulcerative colitis.
    J Crohns Colitis. 2024 Jul 18:jjae108. doi: 10.1093.
    PubMed         Abstract available


    Lancet Gastroenterol Hepatol

  26. VAN DER DOES DE WILLEBOIS EML, Bellato V, Duijvestein M, van der Bilt JDW, et al
    Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2024 Jul 15:S2468-1253(24)00097.
    PubMed         Abstract available

  27. CLICK B, Holubar SD
    Targeting the mesentery with surgery in ileocolic Crohn's disease: where do we stand?
    Lancet Gastroenterol Hepatol. 2024 Jul 15:S2468-1253(24)00186.
    PubMed        


    N Engl J Med

  28. ABRAHAM C
    Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation.
    N Engl J Med. 2024;391:275-277.
    PubMed        

  29. PEYRIN-BIROULET L, Chapman JC, Colombel JF, Caprioli F, et al
    Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
    N Engl J Med. 2024;391:213-223.
    PubMed         Abstract available


    PLoS One

  30. JONES K, Kimble R, Baker K, Tew GA, et al
    Correction: Effects of structured exercise programmes on physiological and psychological outcomes in adults with inflammatory bowel disease (IBD): A systematic review and meta-analysis.
    PLoS One. 2024;19:e0307509.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.